3 Companies Facing FDA Approval: Chelsea, MannKind, and Durata

In a recent slideshow on one-drug wonders, Fool Brian Orelli pointed to three companies that have been very successful after launching their first major drug.

In the video below, he talks with Max Macaluso, the Fool's health care bureau chief, about three companies: Chelsea Therapeutics (NASDAQ: CHTP  ) , MannKind (NASDAQ: MNKD  ) , and Durata Therapeutics (NASDAQ: DRTX  ) , which are looking to launch their first drug if the FDA agrees.

Chelsea Therapeutics is on its second attempt to have its low blood pressure medication Northera approved. MannKind is on its third attempt for its inhaled insulin Afrezza. And Durata Therapeutics is up for an FDA approval for its antibiotic Dalvance.

Another company looking for a big 2014
The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

 


Read/Post Comments (0) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2840145, ~/Articles/ArticleHandler.aspx, 9/22/2014 2:33:13 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement